Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-033718
Filing Date
2017-05-18
Accepted
2017-05-18 18:15:06
Documents
1
Period of Report
2017-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3960
  Complete submission text file 0001209191-17-033718.txt   5451
Mailing Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130 760-260-8600
Retrophin, Inc. (Issuer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RETROPHIN, INC. 12255 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address
McFarlane Neil F. (Reporting) CIK: 0001681098 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36257 | Film No.: 17856024